We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Laboratory Experts Show How They Are Leading the Way on Global Trends

By LabMedica International staff writers
Posted on 27 Jul 2023
Print article
Image: Laboratory experts from around the world shared their experiences and insights at AACC 2023 (Photo courtesy of Freepix)
Image: Laboratory experts from around the world shared their experiences and insights at AACC 2023 (Photo courtesy of Freepix)

As the healthcare sector and technology continue to progress, various initiatives are emerging worldwide to meet the needs of the dynamic landscape. At the "Emerging Trends in Laboratory Medicine: Excellence from the Global Community" session at AACC 2023, moderated by ADLM President Shannon Haymond, Ph.D., three global lab experts shared their knowledge and insights on several trending topics: pandemic readiness, environmental sustainability, and machine learning.

Heungsup Sung from the University of Ulsan College of Medicine (Seoul, Republic of Korea) began the session by discussing necessary measures to prepare for future outbreaks of novel or variant infectious diseases. He highlighted how the cooperation and preparedness between the private and public sectors in Korea during the MERS outbreak in 2015 played a critical role in forming response strategies and guidelines for other infectious diseases. This preparedness laid the groundwork for Korea's rapid response at the onset of the COVID-19 pandemic and aided in reducing mortality rates.

Next, Katherine Hayden, president of the Association for Clinical Biochemistry and Laboratory Medicine (ACB, London, UK), focused on the role of appropriate test utilization in efforts to achieve environmental sustainability. While many laboratorians are aware of the negative impact of poor test utilization on patient outcomes and healthcare costs, they may fail to realize that improper test utilization can also harm the environment. Hayden pointed out that labs contribute 2% of single-use plastics worldwide and generate massive carbon emissions. She outlined various opportunities across all stages of the testing process for labs to enhance utilization and cut down on waste, while sharing strategies to reform lab practices and support sustainability.

In the final segment of the session, ADLM Past President Stephen Master from the Children's Hospital of Philadelphia (Philadelphia, PA, USA) offered advice on employing machine learning in the clinical laboratory. Given the sheer volume of data produced by clinical labs, artificial intelligence and machine learning hold substantial promise for deriving valuable insights that could revolutionize laboratory medicine. However, it's crucial that laboratorians familiarize themselves with best practices for implementing these systems as machine learning tools become increasingly accessible. Master provided several useful resources that lab professionals can refer to for machine learning applications, including a new guidance document developed and published by an IFCC working group.

In order to remain at the forefront of innovation, the laboratory community must adopt new initiatives and be prepared to adapt to evolving situations. The wide-ranging and insightful experiences shared by the session's speakers on pandemic readiness, test utilization and sustainability, and machine learning applications, was well encapsulated by Sung: “The collective knowledge gained from past experiences should serve as a foundation for building a resilient healthcare system capable of effectively addressing future challenges.”

Related Links:
University of Ulsan College of Medicine
ACB
Children's Hospital of Philadelphia

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Creatine Kinase-MB Assay
CK-MB Test
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.